检索结果 - Emil Vilstrup
- Showing 1 - 1 results of 1
-
1
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. 由 Jesper Damsgaard Gunst, Nina Breinholt Stærke, Marie H. Pahus, Lena Hagelskjær Kristensen, Jacob Bodilsen, Nicolai Lohse, Lars Dalgaard, Dorthe Brønnum, Ole Fröbert, Bo Langhoff Hønge, Işık Somuncu Johansen, Ida Monrad, Christian Erikstrup, Regitze Rosendal, Emil Vilstrup, Theis Mariager, Dorthe Gaby Bové, Rasmus Offersen, Shakil Shakar, Sara Cajander, Nis Pedersen Jørgensen, Sajitha Sophia Sritharan, Peter Breining, S.K. Jespersen, Klaus Leth Mortensen, Mads Langballe Jensen, Lilian Kolte, Giacomo S. Frattari, Carsten Schade Larsen, Merete Storgaard, Lars Peter Nielsen, Martin Tolstrup, Eva Aggerholm Sædder, Lars Østergaard, Hien T. T. Ngo, Morten Hasselstrøm Jensen, Jesper Falkesgaard Højen, Mads Kjølby, Ole S. Søgaard
出版 2021Artigo
相关主题
2019-20 coronavirus outbreak
Alternative medicine
Coronavirus disease 2019 (COVID-19)
Disease
Double blind
Infectious disease (medical specialty)
Internal medicine
Medicine
Outbreak
Pathology
Placebo
Randomized controlled trial
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
TMPRSS2
Virology